1.
Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality
by Anderson, Simon G
Heart (British Cardiac Society), 2016-11, Vol.102 (21), p.1750-1756

2.
Rationale and design of dal-PLAQUE: A study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fl...
by Fayad, Zahi A., PhD
The American heart journal, 2011, Vol.162 (2), p.214-221.e2

3.
Rapid Blood Pressure Lowering According to Recovery at Different Time Intervals after Acute Intracerebral Hemorrhage: Pooled Analysis of the INTERACT Studies
by Wang, Xia
Cerebrovascular diseases (Basel, Switzerland), 2015-04, Vol.39 (3-4), p.242-248
